Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Suman Garlapati

Suman Garlapati

Suman Garlapati, PhD
Scientist
InvaGen Pharmaceuticals Inc
USA
Tel: 1-914-486-1898

Biography

Dr. Suman Garlapati, born and brought up at Khammam Dist, AP, India, Aug 6, 1981; BS in Biotech from Kakatiya University (2001), MS in Biotech, Bharathidasan University (2003), Ph.D. University. Mysore (2008), MBA in Production Management MKU (2010), Selected Post Doc Fellow from Oregon State University. Oregon, USA. Presently working as a Drug Safety & Pharmacovigilance Officer InvaGen Pharm, Inc (2009), Trained Pharmacovigilance specialist from i3 CanReg, Canada, Certified MedDRA Coder, USA– Recipient Prof. D.C. Cooper, Rajyapuraskar, Soc. Cytology & Genetics, Indian Govt. Executive council member of INC Res (Kendle, Inc). Anti-Retroviral Pregnancy Registry.

Research Interest

Obesity, Leptin gene disorders, Cancer Biology, Genetic Toxicology and Bioinformatics.

Certificate

Certificate

Global Speakers in the subject

Global Experts in the subject

Publications

Useful Notes for the Obese: Bariatric Surgical Procedures

A Highly Suggested Surgical Method for a Most Unwanted Problem -Bariatric Vs Obesity

Suman Garlapati
Editorial: J Obes Weight Loss Ther
DOI: 10.4172/2165-7904.1000e106
Suman Garlapati
Editorial: J Obes Weight Loss Ther
DOI: 10.4172/2165-7904.1000e104
Relevant Topics
Top